Bristol Myers Squibb Company articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2013/05/17 14:48
2013/05/17 14:48
1d
... of times I've seen response rates like this." The study was funded by Genentech/Roche, the company that is developing the drug. The results were presented at a Wednesday news conference...
2013/05/17 14:48
2013/05/17 14:48
Latest videos
2013/05/17 14:48
2013/05/17 14:48
Latest from Twitter
2013/05/17 05:58
2013/05/17 05:58
1d
... talking point. Shares of networking gear manufacturer Cisco Systems rocketed by 13% after the company unveiled stronger than forecast third quarter profits. Standard&Poor's downgraded the...
2013/05/16 15:47
2013/05/16 15:47
2d
... come undone? JOSEPH MOLLICA WAS in a bind and Sam Isaly knew it. Last summer Mollica's company, Princeton, N.J.-based Pharmacopeia, had announced plans to buy Eos Biotechnology, a small...
2013/05/16 11:28
2013/05/16 11:28
2d
... where a contract document is available in the public domain. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing...
2013/05/16 08:26
2013/05/16 08:26
2d
... auditorswith less regularity, they find. Prof Yermack and colleagues take the example of Bristol-Myers Squibb, the pharmaceutical company, as one prominent exponent of such accounting...
2013/05/16 06:34
2013/05/16 06:34
2d
... Systems Inc shares rose 6.5 percent to $22.59 in extended-hours trading after the company posted a higher-than-expected quarterly profit, suggesting that the network equipment...
2013/05/15 23:39
2013/05/15 23:39
3d
Systems Inc shares rose 6.5 per cent to US$22.59 in extended-hours trading after the company posted a higher-than-expected quarterly profit, suggesting that the network equipment...
2013/05/15 22:58
2013/05/15 22:58
3d
... week and was 10% higher than the same week one year ago. Shares in biopharmaceuticals companyBristol-Myers Squibb advanced as it announced that new data on its approved and...
2013/05/15 06:56
2013/05/15 06:56
3d
... percent and Goldman Sachs put on 3.3 percent. Some pharmaceutical firms also fared well. Bristol-Myers Squibb rose 3.1 percent, Gilead Sciences added 3.3 percent and Biogen Idec jumped 3.2...
2013/05/14 04:16
2013/05/14 04:16
5d
... in Philadelphia, fell 0.5 percent to $42.86 at 1:50 p.m. in New York. Shares of the company, which paid $16.7 billion to complete its purchase of NBC Universal this year, had climbed...
Read more at BusinessWeek, Bloomberg
2013/05/13 09:17
2013/05/13 09:17
5d
... U.S.,” said n3D President and CSO Dr. Glauco Souza. It’s exciting news for RBCC, as well. The company signed a joint venture agreement to help develop and market the BioAssembler last year....
2013/05/10 19:17
2013/05/10 19:17
8d
... hematology partnering deals signed and announced since 2007. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing...
2013/05/08 18:17
2013/05/08 18:17
10d
... a comprehensive appendix is provided organized by companion diagnostics partnering company A-Z , deal type definitions and companion diagnostics partnering agreements example. Each...
2013/05/08 06:30
2013/05/08 06:30
10d
... this week, and Apple Inc. is more widely held than ever after dips in the technology company’s share price attracted buyers. The Omaha-based online stock brokerage and wealth manager...
2013/05/07 14:52
2013/05/07 14:52
11d
Harrisburg in two separate but similar cases involving Big Pharma companies. Johnson & Johnson and Bristol-Myers Squibb, among other companies, were accused of improperly reporting the so-called...
2013/05/06 11:17
2013/05/06 11:17
12d
CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy, today...
2013/05/06 09:17
2013/05/06 09:17
12d
... the future of cellular research,” Brown said. “We anticipate an explosion of interest in the company and its products as a result of this terrific Nature article.” Rainbow BioSciences will...
2013/05/04 11:12
2013/05/04 11:12
14d
... won corporate-sponsored National Merit Scholarship awards financed by about 200 corporations, company foundations and other business organizations nationwide, according to corporation...
2013/05/03 19:06
2013/05/03 19:06
15d
... and helped to raise financing. Newton advised drugmaker Amylin Pharmaceuticals Inc. when the company was sold last year to Bristol-Myers Squibb Co. for $5.3 billion. They will report to Tom...
2013/05/03 10:17
2013/05/03 10:17
15d
Gilead announced the completion of its acquisition of YM, a publicly-held drug development company that was primarily focused on advancing its lead product candidate momelotinib (formally...